Priscilla Lemes

Priscilla Lemes possesses an extensive academic background with degrees in Science and Technology and Biomedical Engineering and Neurosciences from the Federal University of ABC (UFABC). Her professional journey spans nearly seven years, during which she has developed a specialization in In Silico Clinical Trials. Ms. Lemes serves on several influential regulatory standards committees, including the Brazilian National Committee ABNT for Biological and Clinical Evaluation of Medical Devices, the International Standard Organization Committee for Clinical Investigations of Medical Devices in Humans, and the Brazilian National Working Group for the International Standard Organization for Cardiovascular implants. Her active role in these committees involves reviewing and aiding in the development of critical standards such as ISO 14155 and 18969. An expert in global regulatory pathways, Ms. Lemes has acquired substantial knowledge and experience with the regulatory frameworks of various regions, including Poland, Greece, Estonia, the Nordic countries, the Middle East, and Latin America. She is dedicated to keeping abreast of the latest developments in regulatory and clinical standards, trends, and training. Her recent publication, the first scientific paper on In Silico Clinical Trial acceptance in Brazil, marks a significant contribution to the field, reinforcing her status as a thought leader in medical device regulation and clinical trial methodologies.